Table 3 Clinical data of patients with HHS on admission

Number of patients

58

16

Age (year)

74.7 ± 12.3

78.3 ± 8.2

Gender (male: female)

19:39

7:9

History of DM (years)

7.47 ± 6.73

3 (2–10)

Hospital stay (days)

19.67 ± 12.90

5.5 (3–19.75)

Expenses (Yuan)

16,988.2 ± 10,927.4

8680.5 (2974.6–23,185.4)

RBG (mmol/L)

34.44 ± 1.96

33.66 ± 0.57

HbA1c(%)

10.58 ± 2.64

11.46 ± 3.74

Fasting C-peptide (ng/mL)

0.95 ± 0.68

0.31 (0.10–2.27)

EPO (mOsm/L)

380.76 ± 20.93

394.58 ± 23.61^*

Na + (mmol/L)

169.88 ± 8.34

161.31 ± 8.19

BUN (mmol/L)

18.61 ± 10.05

29.70 ± 12.98^**

Cr (umol/L)

151.86 ± 86.25

194.5 (159–232.75)^*

ALT(U/L)

21.5 (13–32.25)

36.5 (21.25–86.25)

AST(U/L)

23 (16–37.5)

35.0 (23.0–145.0)

Percentage of CSII therapy (%)

50.0 (29/58)

18.8 (3/16)^*